Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar

Figure 2

Proportions of febrile patients following treatment. CQ, Chloroquine, AQ, Amodiaquine; SP, Sulfadoxine-Pyrimethamine; AS, artesunate; On day 1, Significant difference to SP group (P < 0.05), SP vs. AQ+SP, SP vs. AQ+AS; At day 2, Significant difference to SP group (P < 0.05), SP vs. AQ+AS; On day 14, Significant difference to CQ group (P < 0.05), CQ vs. AQ, CQ vs. SP, CQ vs. AQ+SP, CQ vs. AQ+AS

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us